Section of Infectious Diseases and Global Health
Associate Professor of Medicine
Chief Medical Officer and Vice President for Clinical Effectiveness, University of Chicago Medical Center; Medical Director, Infection Control and Clinical Quality
|MD||1995||New York University||
|Residency||1998||The University of Chicago||Internal Medicine
|Residency||1999||The University of Chicago||Chief Resident
|MS||2002||Harvard School of Public Health||Epidemiology
|Fellowship||2002||Beth Israel Deaconess Medical Center||Infectious Diseases
Dr. Weber is the Chief Healthcare Epidemiologist and Medical Director of the Infection Control Program. His research interests focus on healthcare-associated infections, particularly those caused by multi-drug resistant organisms among hospitalized patients. With his research, Dr. Weber seeks to identify novel individual, population-based and institutional risk factors that influence the likelihood of these infections. In doing so, he collaborates with colleagues across the institution and at other centers to devise novel approaches to the prevention of infection.
Dr. Weber’s research has led him to become engaged in issues regarding the practice of infection prevention in the wider community. In addition to playing an active role in infection prevention policy debates at both the state and federal level, Dr. Weber is a founding member of the Chicago Healthcare Epidemiology Roundtable, a consortium of local experts who promote transparency and innovation in infection prevention across the area.
Healthcare associated infections; Complicated infectious issues in the elderly.
- Sreeramoju P, Tolentino J, Garcia-Houchins S, Weber SG. Predictive Factors for the Development of Central Line – Associated Bloodstream Infection due to Gram Negative Bacteria in Intensive Care Unit Patients after Surgery. Infect Control Hosp Epidemiol 2008; 29: 51-6.
- Vora S, Damon I, Fulginiti V, Weber SG, Kahana M, Stein SL, et al. Severe eczema vaccinatum in a household contact of a smallpox vaccinee. Clin Inf Dis 2008; 46: 1555-61.
- Sreeramoju P, Garcia-Houchins S, Bova J, Kelly CC, Patterson JE, Weber SG. Correlation between Respiratory Colonization and Development of Infection with Gram-Negative Bacteria after Cardiac Surgery. Infect Control Hosp Epidemiol 2008; 29: 546-48.
- Calderwood MS, Mauer A, Tolentino J, Flores E, van Besian K, Pursell K, Weber SG. Epidemiology of vancomycin-resistant enterococci among patients on an adult stem cell transplant unit: observations from an active surveillance program. Infection Control Hosp Epidemiol 2008; 29: 1019-25
- Kaye KS, Kanafani ZA, Dodds AE, Engemann JJ, Weber SG, Carmeli Y. Differential effects of levofloxacin and ciprofloxacin on the risk for isolation of quinolone-resistant Pseudomonas aeruginosa. Antimicrob Agents Chemother 2006; 50: 2192-6.